Literature DB >> 30890889

The relationship between the apolipoprotein E e4 allele and hippocampal magnetic resonance imaging volume in community-dwelling individuals with mild Alzheimer's disease.

Bernard Walsh1, Stuart Slater2, Balakrishnan Nair3, John Attia3.   

Abstract

BACKGROUND: The degree of hippocampal magnetic resonance imaging (MRI) volume loss in Alzheimer's disease (AD) is commonly accepted as a marker of disease severity, yet remains expensive, unavailable, or not tolerated by many patients. AIM: To examine whether the presence of one or more apolipoprotein E (ApoE) e4 alleles is associated with smaller hippocampal MRI volumes in a population of early AD patients.
METHODS: A total of 88 consecutive patients attending a community-based memory disorders clinic who had both mild dementia on the Clinical Dementia Rating scale and Diagnostic and Statistical Manual of Mental Disorders criteria for probable AD were recruited. We examined the relationship between ApoE e4 allele load and hippocampal atrophy on MRI volumes.
RESULTS: There was no association between the ApoE e4 load and hippocampal volume in this cohort.
CONCLUSION: This study suggests that the presence of one or more ApoE e4 alleles cannot be used to estimate pathological disease load in early AD.

Entities:  

Keywords:  Alzheimer’s disease; MRI; apolipoprotein E; hippocampus

Year:  2013        PMID: 30890889      PMCID: PMC6065553          DOI: 10.2147/DNND.S40835

Source DB:  PubMed          Journal:  Degener Neurol Neuromuscul Dis        ISSN: 1179-9900


  13 in total

1.  Apolipoprotein E epsilon4 allele, temporal lobe atrophy, and white matter lesions in late-life dementias.

Authors:  R Barber; A Gholkar; P Scheltens; C Ballard; I G McKeith; C M Morris; J T O'Brien
Journal:  Arch Neurol       Date:  1999-08

2.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

3.  Selective effect of Apo e4 on CA3 and dentate in normal aging and Alzheimer's disease using high resolution MRI at 4 T.

Authors:  S G Mueller; N Schuff; S Raptentsetsang; J Elman; M W Weiner
Journal:  Neuroimage       Date:  2008-04-22       Impact factor: 6.556

4.  Apolipoprotein E epsilon4 is associated with atrophy of the amygdala in Alzheimer's disease.

Authors:  Michael Basso; Joel Gelernter; John Yang; Martha G MacAvoy; Pradeep Varma; Richard A Bronen; Christopher H van Dyck
Journal:  Neurobiol Aging       Date:  2005-09-22       Impact factor: 4.673

5.  The Clinical Dementia Rating (CDR): current version and scoring rules.

Authors:  J C Morris
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

6.  APOE-epsilon4 is associated with less frontal and more medial temporal lobe atrophy in AD.

Authors:  C Geroldi; M Pihlajamäki; M P Laakso; C DeCarli; A Beltramello; A Bianchetti; H Soininen; M Trabucchi; G B Frisoni
Journal:  Neurology       Date:  1999-11-10       Impact factor: 9.910

7.  Apolipoprotein E epsilon 4 and the pattern of regional brain atrophy in Alzheimer's disease.

Authors:  M Hashimoto; M Yasuda; S Tanimukai; M Matsui; N Hirono; H Kazui; E Mori
Journal:  Neurology       Date:  2001-10-23       Impact factor: 9.910

8.  Volumes of hippocampus, amygdala and frontal lobe in Alzheimer patients with different apolipoprotein E genotypes.

Authors:  M Lehtovirta; M P Laakso; H Soininen; S Helisalmi; A Mannermaa; E L Helkala; K Partanen; M Ryynänen; P Vainio; P Hartikainen
Journal:  Neuroscience       Date:  1995-07       Impact factor: 3.590

Review 9.  The role of apolipoprotein E in Alzheimer's disease.

Authors:  Jungsu Kim; Jacob M Basak; David M Holtzman
Journal:  Neuron       Date:  2009-08-13       Impact factor: 17.173

10.  MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers.

Authors:  N Schuff; N Woerner; L Boreta; T Kornfield; L M Shaw; J Q Trojanowski; P M Thompson; C R Jack; M W Weiner
Journal:  Brain       Date:  2009-02-27       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.